Advertisement
Research Article

Perinatal Outcomes by Mode of Assisted Conception and Sub-Fertility in an Australian Data Linkage Cohort

  • Jennifer L. Marino,

    Affiliation: Department of Obstetrics and Gynaecology, The University of Melbourne, Royal Women's Hospital, Parkville, Victoria, Australia

    X
  • Vivienne M. Moore,

    Affiliations: Discipline of Public Health, The University of Adelaide, Adelaide, South Australia, Australia, Robinson Institute, The University of Adelaide, Adelaide, South Australia, Australia

    X
  • Kristyn J. Willson,

    Affiliation: Discipline of Public Health, The University of Adelaide, Adelaide, South Australia, Australia

    X
  • Alice Rumbold,

    Affiliations: Robinson Institute, The University of Adelaide, Adelaide, South Australia, Australia, Discipline of Obstetrics and Gynaecology, The University of Adelaide, Adelaide, South Australia, Australia

    X
  • Melissa J. Whitrow,

    Affiliations: Discipline of Public Health, The University of Adelaide, Adelaide, South Australia, Australia, Robinson Institute, The University of Adelaide, Adelaide, South Australia, Australia

    X
  • Lynne C. Giles,

    Affiliations: Discipline of Public Health, The University of Adelaide, Adelaide, South Australia, Australia, Robinson Institute, The University of Adelaide, Adelaide, South Australia, Australia

    X
  • Michael J. Davies mail

    michael.davies@adelaide.edu.au

    Affiliations: Robinson Institute, The University of Adelaide, Adelaide, South Australia, Australia, Discipline of Obstetrics and Gynaecology, The University of Adelaide, Adelaide, South Australia, Australia

    X
  • Published: January 08, 2014
  • DOI: 10.1371/journal.pone.0080398

Abstract

Background

Fertility treatment is associated with increased risk of major birth defects, which varies between in vitro fertilisation (IVF) and intracytoplasmic sperm injection (ICSI), and is significantly reduced by embryo freezing. We therefore examined a range of additional perinatal outcomes for these exposures.

Methods

All patients in South Australia receiving assisted conception between Jan 1986–Dec 2002 were linked to the state-wide perinatal collection (all births/stillbirths ≥20 weeks gestation or 400 g birth weight, n = 306 995). We examined stillbirth, mean birth weight, low birth weight (<2500 g, <1500 g), small size for gestational age (<10th percentile, <3rd percentile), large size for gestational age (>90th percentile), preterm birth (32–<37 weeks, <32 weeks gestation), postterm birth (≥41 weeks gestation), Apgar <7 at 5 minutes and neonatal death.

Results

Relative to spontaneous conceptions, singletons from assisted conception were more likely to be stillborn (OR = 1.82, 95% Confidence Interval (CI) 1.34–2.48), while survivors as a group were comprehensively disadvantaged at birth, including lower birth weight (−109 g, CI −129–−89), very low birth weight (OR = 2.74, CI 2.19–3.43), very preterm birth (OR = 2.30, CI 1.82–2.90) and neonatal death (OR = 2.04, CI 1.27–3.26). Outcomes varied by type of assisted conception. Very low and low birth weight, very preterm and preterm birth, and neonatal death were markedly more common in singleton births from IVF and to a lesser degree, in births from ICSI. Using frozen-embryos eliminated all significant adverse outcomes associated with ICSI but not with IVF. However, frozen-embryo cycles were also associated with increased risk of macrosomia for IVF and ICSI singletons (OR = 1.36, CI 1.02–1.82; OR = 1.55, CI 1.05–2.28). Infertility status without treatment was also associated with adverse outcomes.

Conclusions

Births after assisted conception show an extensive range of compromised outcomes that vary by treatment modality, that are substantially reduced after embryo freezing, but which co-occur with an increased risk of macrosomia.

Introduction

While birth outcomes after assisted conception have been studied, particularly descriptively, and subject to meta-analysis [1][5], few studies have been designed or scaled to permit comparisons of outcomes among different types of assistance [6], and separately for singletons and twins. Additionally, although fertility impairment itself has a negative impact on birth outcomes [7][10], only two studies [11], [12], both restricted to singletons, have examined the effects of subfertility and mode of conception in the same patient population.

We have recently demonstrated that treatment modality, subfertility and embryo freezing each contribute to the risk of major birth defects [13]. Here we examine the impact of assisted conception method and fertility impairment on a range of perinatal outcomes other than major birth defects, separately for singleton and twin births, and with adjustment for common confounders.

Methods and Materials

Data source

As previously described [13], we created a database linking all infertility treatment in South Australia between January 1986 and December 2002 to the contemporaneous state perinatal collection. The perinatal collection details all live births and stillbirths of at least 20 weeks' gestation or 400 g birth weight (around 20,000/year), including birth weight, gestational age, and maternal pre-existing and gestational medical conditions. The two clinics in the state licensed to manipulate gametes (the University of Adelaide and Flinders University) provided data for all patient visits for the period. The resulting de-identified database includes information for 327,378 registered births (321,210 spontaneously conceived).

Exclusions

There were 20,383 exclusions. The majority (n = 18,420, 90.4%) were pregnancies among mothers under 20 years of age as only 2 of these pregnancies were conceived with infertility treatment. Births of higher-order multiplicity (triplet and quadruplet) were also excluded because appropriate size references do not exist. As all analyses were adjusted for infant sex of the baby, 311 births and terminations of indeterminate sex and where the sex was unknown were also excluded (n = 304 (0.1%) conceived spontaneously and n = 7 (0.1%) conceived with infertility treatment).

Exposures and covariates

Births after any assisted conception (n = 5,949) were compared to those after spontaneous conception (n = 301,046). The spontaneous conception group was further classified into births to women with no history of infertility in their records and no infertility treatment (“spontaneous conception, fertile”, n = 298,952), births to women who had a recorded diagnosis of infertility but no associated assisted conception treatment from a specialist clinic (“spontaneous conception, IF DX”, n = 767), and births as a result of spontaneous conception in women with a previous birth from assisted conception (“spontaneous conception, IF TX”, n = 1,327).

Types of assisted conception considered were: donor oocyte procedures, gamete intrafallopian transfer (GIFT), intrauterine insemination (IUI), in vitro fertilization (IVF) with fresh-embryo cycles, IVF with frozen-embryo cycles, intracytoplasmic sperm injection (ICSI) with fresh-embryo cycles, ICSI with frozen-embryo cycles, minimal medical intervention and ovulation induction (OI) only. Conceptions with donor oocytes were grouped together irrespective of mode of assisted conception. Conceptions resulting from IUI only (n = 702) and IUI after cancellation of IVF (n = 11) or ICSI (n = 2) were grouped.

The IVF with fresh-embryo transfer group (n = 1519) included pregnancies arising from zygote intrafallopian transfer (ZIFT) or tubal embryo transfer (TET) (n = 9) (as such treatments have medication and culture regimens similar to those of IVF), and all natural-cycle (n = 12) and OI (n = 1,498) IVF pregnancies not specifying embryo transfer. All pregnancies involving donor embryos (n = 9), imported embryos (n = 10), and IVF specifying “embryo transfer” with or without mentioning freezing (respectively n = 39, n = 546) were included in the IVF with frozen-embryo transfer group (n = 604).

The minimal medical intervention group (n = 710) included conceptions in women who were tracking their ovulatory cycles in anticipation of starting treatment or who were being monitored for other reasons (n = 167), to women who received donor insemination (n = 466), to a woman whose primary treatment was weight loss, to a woman whose husband was treated with human chorionic gonadotrophin (hCG); conservatively, these women were counted among this group because it is possible that some received hormonal medication to adjust ovulation timing, even though this was not recorded in their medical records (for example, medication prescribed outside of the licensed fertility clinic). As well, conceptions during ovarian suppression regimens (n = 69) and after tubal or ovarian surgery (n = 6) were counted in this group.

The OI only group (n = 406) included pregnancies among those who received only an OI regimen (clomiphene citrate +/− bromocryptine) (n = 386), those who were tracking their cycles and receiving OI regimens (n = 7), and those whose IUIs were cancelled for ovarian hyperstimulation (n = 4). The group also included pregnancies arising during IUI control cycles (n = 6), and from donor insemination after IVF cancellation (n = 3), as it was likely that such women had begun OI or that ovarian hyperstimulation was the reason for cancellation.

Outcomes

Birth outcomes considered were stillbirth, birth weight, very low birth weight (VLBW, <1,500 g), low birth weight (LBW, <2,500 g), very preterm birth (VPTB, <32 weeks gestation), preterm birth (PTB, <37 weeks gestation), postterm birth (>41 weeks gestation), very small size for gestational age (VSGA, <3rd percentile), small size for gestational age (SGA, <10th percentile), large size for gestational age (LGA, >90th percentile), Apgar score <7 at 5 minutes, and neonatal death. Analyses of birth outcomes other than stillbirth were restricted to liveborn singletons (n = 296,401) and twins (n = 8,824). Australian national standards for sex-specific birth weight centiles by gestational age were used to define VSGA, SGA, and LGA separately for singletons [14] and twins [15].

Analyses were stratified by plurality. Generalized estimating equations were used to produce odds ratios accounting for clustering of births within women. All analyses were adjusted for maternal age, parity, and infant sex; those for twin analyses were further adjusted for same-sex twinship to reduce the role of fetal zygosity. Within some assisted conception groups, certain outcomes were too rare for stratification. In these circumstances, groups were combined within type of conception first (i.e. singletons and twins were grouped together) and then if necessary, assisted conception groups were combined according to similarity of treatment. Where singletons and twins were grouped, models were fitted to force the estimates for modality to be the same for both groups, with multiplicity-specific comparators (i.e. the reference group for singletons born after the modality was spontaneously conceived singletons, and for twins born after the modality was spontaneously conceived twins.) All statistical analyses were performed using SAS 9.2 (©2009 SAS Institute Inc., Cary, NC).

Ethics approval

Approval for the study was obtained from the ethics committees of the South Australian Department of Health, the University of Adelaide, and Flinders University. Individual level consent was not required.

Results

Table 1 summarizes characteristics of live births and stillbirths by mode of conception. For both types of birth, women who used assisted conception were significantly older and less likely to have had a previous birth than women who conceived spontaneously.

thumbnail

Table 1. Characteristics of live births and stillbirths by mode of conception.

doi:10.1371/journal.pone.0080398.t001

Stillbirth

Table 2 shows associations between assisted conception and stillbirth. Singletons from any assisted conception treatment were almost twice as likely to be stillborn than those conceived spontaneously.

thumbnail

Table 2. Stillbirth among singletons and twins by mode of conception.

doi:10.1371/journal.pone.0080398.t002

Compared to spontaneous conceptions in women with no recorded infertility history or infertility treatment (spontaneous conception, fertile group), spontaneous conceptions to women with a recorded infertility diagnosis but no treatment (spontaneous conception, IF DX group), and conceptions achieved with GIFT, with IVF with fresh-embryo cycles, and with ICSI with fresh-embryo cycles were more likely to end in stillbirth. Conceptions resulting from IVF with frozen-embryo cycles were more likely to be stillborn than the fertile group, but the difference did not reach statistical significance. There were no differences in stillbirth risk among twins by mode of conception.

Liveborn singletons

Table 3 shows associations between birth outcomes and mode of conception among singletons. Compared to births from spontaneous conceptions, births from any assisted conception were significantly lighter at birth, more often born VLBW, LBW, very preterm, preterm, VSGA, and SGA, and were more likely to die in the neonatal period. They were significantly less likely to be born postterm but did not differ in likelihood of LGA or an Apgar score <7 at 5 minutes.

thumbnail

Table 3. Perinatal outcomes among singleton live births by mode of conception.

doi:10.1371/journal.pone.0080398.t003

Relative to the spontaneous conception, fertile group, infants of women with a recorded infertility diagnosis but no treatment were significantly lighter, more likely to be born VLBW or LBW, very preterm or preterm, and VSGA, were more likely to have a an Apgar score <7 at 5 minutes, and were more likely to die in the neonatal period. Infants of women with a previous assisted conception birth (spontaneous conception, IF TX group) were less likely to be born postterm, VSGA or SGA than the spontaneous conception, fertile group. However there were no other differences in outcomes between these groups.

Compared to the spontaneous conception, fertile group, infants as a result of donor oocytes did not differ significantly in mean birth weight, but were at increased risk of being born VLBW, LBW or very preterm. Infants resulting from GIFT were lighter, and were more likely to be born VLBW, LBW, very preterm, VSGA, and SGA, and less likely to be postterm. IUI infants were lighter at birth and more likely to be VLBW, LBW, preterm, or VSGA, and less likely to be postterm.

Infants from IVF with fresh-embryo cycles were lighter at birth and more likely to be born VLBW, LBW, very preterm or preterm, SGA, and were more likely to die in the neonatal period. They were also less likely to be postterm or LGA than those in the spontaneous conception, fertile group. Among infants from IVF with frozen-embryo cycles, there was no increased risk of neonatal death, VLBW or VPTB, however the associations with LBW, PTB, and SGA remained, and there was an increased risk of LGA. Infants from ICSI with fresh-embryo cycles were lighter, had increased risks of LBW, VSGA, SGA and a decreased risk of being postterm or LGA. However, the associations between ICSI and adverse perinatal outcomes were no longer present for ICSI with frozen-embryo cycles. In fact, these infants were significantly heavier and more likely to be LGA than those in the spontaneous conception, fertile group.

Infants of women in the minimal medical intervention group were less likely to be postterm and did not otherwise differ from the spontaneous conception, fertile group infants. Use of ovulation induction alone was associated with an increased risk of LBW and PTB.

Liveborn twins

Table 4 shows associations between outcomes by mode of conception among twins. Compared to those conceived spontaneously, twin babies conceived with any assisted conception were born lighter and were more often born VLBW or very preterm. Relative to twins born to the spontaneous conception, fertile group, those in the spontaneous conception, IF DX group were born lighter and were more likely to be VLBW and die in the neonatal period. Twins conceived spontaneously in women with a previous assisted conception birth were less likely to be VSGA than twins in the spontaneous conception, fertile group.

thumbnail

Table 4. Perinatal outcomes among twin live births by mode of conception.

doi:10.1371/journal.pone.0080398.t004

Compared to twin births in the spontaneous conception, fertile group, twins from GIFT were less likely to be LGA, twins from IUI were more likely to be VLBW, those from IVF with fresh-embryo cycles were born lighter, those born after ICSI with fresh-embryo cycles were less likely to be SGA and those born after ICSI with frozen-embryo cycles were more likely to be LGA.

Discussion

In this large, population-based dataset, singleton births resulting from any assisted conception had almost double the risk of stillbirth of those conceived spontaneously. Liveborn infants from assisted conception were significantly more likely to be born preterm, be compromised on a range of indicators of birth size, and die in the neonatal period compared to their spontaneously conceived counterparts. These findings are consistent with those of recent studies [8], [16], with risk estimate magnitudes very similar to those in two earlier meta-analyses [4], [5]. However, our study represents a significant advance on previous studies as we were able to comprehensively demonstrate that the risks of adverse outcomes varied by type of assisted conception.

Among singletons, the increased risk of stillbirth was present for births resulting from fresh-embryo cycles of IVF or ICSI (but not frozen) and GIFT. Although an increased risk of stillbirth has been associated with IVF/ICSI relative to spontaneous conceptions and non-IVF treatments [17], our study is the first to demonstrate separate effects for the invasive assisted reproductive technologies, and to document an increased risk in women with a history of infertility but no treatment. We found very low birth weight, low birth weight, very preterm birth, preterm birth and neonatal death were markedly more common (ranging from a two to five-fold increase) and postterm birth less common among singletons conceived using IVF with fresh-embryo cycles than among those spontaneously conceived by fertile couples. Our results regarding birth size are consistent with previous studies demonstrating an association between IVF and smaller birth size [16], [18], [19]. However, the magnitude of the difference observed in this study (250 g reduction among IVF with fresh-embryo cycle births) is greater than in previous studies.

We also found increased risk of adverse outcomes among births from ICSI with fresh-embryo cycles, but the effects appeared considerably weaker than those seen for IVF. Studies of the Swedish IVF Registry [20] found no such differences between ICSI and IVF, even after taking cryopreservation effects into account, consistent with a clinical study [21]. However, the Swedish study pooled singletons and twins for the comparison of IVF and ICSI, which we suggest may attenuate observed effects. We also here confirmed the association between OI and an increased risk of low birth weight and preterm birth reported elsewhere [22][24].

Embryos transferred after cryopreservation may have better outcomes than those transferred fresh [25][28]. This apparent advantage has been attributed to the selection effect of freezing, whereby developmentally compromised embryos are less likely to survive, and to the placement of the cryopreserved embryo in a uterine milieu which has recovered from the effects of hormonal stimulation [25]. Although a previous systematic review [29] found no difference between frozen and fresh-embryo transfer, a recent meta-analysis found consistently better outcomes among pregnancies arising after frozen-embryo transfer [30]. However, neither took into account the use of ICSI. A Danish birth registry study found significant reductions in risk of preterm birth and low birth after cryopreservation that occurred in both IVF and ICSI, [26]. In the present dataset, we previously reported that cryopreservation was significantly protective against birth defects in ICSI, but not IVF, where the risks in fresh cycles were relatively low [13]. In the present study, cryopreservation reduced risk magnitudes for stillbirth, small birth size and early delivery outcomes for IVF, and eliminated those risks for ICSI. It is uncertain why cryopreservation may be more beneficial in ICSI than IVF treatment. However, this may reflect differences in the characteristics of patients accessing these treatments, as ICSI was generally used for male infertility and IVF for female infertility. Hence, IVF cycles may have a higher proportion of female-factor only patients where the selection effect of a freeze-thaw cycle may be diluted. Alternatively, there may be an ICSI-specific effect on growth patterns. We observed that frozen-embryo transfer was associated with increased likelihood of large size for gestational age among singletons born after ICSI. This association has been reported previously, albeit in studies that pooled IVF and ICSI cycles [31], [32]. However, caution is warranted in the interpretation of findings for the ICSI with frozen-embryo cycles group as the number of patients treated in this way is small, and data are pooled for singletons and twins for some outcomes. Further research is required to understand the cause of these possible risk differentials and their impact on longer term health outcomes, particularly with regard to the potential for perturbation of the fetal epigenome [33].

The contribution of maternal risk factors (other than maternal age) to the observed treatment effects is unclear, as we did not adjust for infertility aetiology. The apparent differences in risk between IVF and ICSI may be due in part to factors related to both specific infertility treatments and adverse pregnancy outcomes, such as obesity [34]. Although there is some evidence that the higher risk of stillbirth in assisted conceptions is explained by treatment type not cause of infertility [17], further research is needed to elucidate the influence of parental factors and treatment effects on the range of outcomes considered in this study.

We separated spontaneous conceptions to women diagnosed with infertility but never treated from those to women previously treated, and we consistently found that negative consequences were limited to those diagnosed but untreated. Some outcomes indicated serious disadvantage, such as a quadrupling in risk of stillbirth, a 7-fold increase in neonatal death and an over 250 g deficit in birth weight. Adverse effects of subfertility on birth size and gestational age at birth have been observed previously [7], [9], [35], [36]. We cannot exclude residual confounding by the use of poorly supervised clomiphene citrate, also associated with smaller birth size [22][24] as we have previously reported that of women with a history of infertility, approximately half use intensive therapies through specialist clinics, while others use clomiphene citrate as a first line treatment that is not recorded in the data available for this study [37]. This group of births should be studied further to identify their pattern of exposure to fertility treatments and maternal factors.

Twins conceived with any assisted conception treatment were slightly lighter than spontaneously conceived twins. They were modestly more likely to be born at very low birth weight, and to be born very preterm, and had the same risk of neonatal mortality. This supports existing observations of outcomes among twins conceived with infertility treatment [38][40]. There were few differences in outcomes among twins by type of assisted conception treatment.

This large population-based study linked all assisted conception births in the state to outcomes obtained from the birth register. Unlike many prior registry studies, our analytic approach accounted for clustering within woman (by sibship) and within twins [41].

Limitations include the absence of information about: changes of male partner during interpregnancy intervals; zygosity and chorionicity of twins; and whether twins and singletons were reductions of higher-order pregnancies. Data were not available for assisted conception pregnancies beyond 2002. While improvements in pregnancy outcomes after assisted conception have been noted in the intervening years, these are primarily attributable to reductions in multiple pregnancy [42], with a further potential contribution from increasing use of cryopreservation [32]. Nevertheless, births after assisted conception continue to have a range of adverse perinatal outcomes [43], and therefore the results of this study, particularly the stratified analyses, are likely to have continued relevance internationally. A further potential limitation is that specialists may prescribe OI medications outside of specialist IVF clinics in South Australia, so some OI pregnancies may have been misclassified as spontaneous, and risks associated with assisted conception attenuated. However, we have ascertained from a registry of prescription data that this could contribute less than 1% of all births and is therefore a minor source of error for outcomes in the general population, but may contribute to the excess risk for uncommon outcomes, such as a stillbirth, in the group described above as the infertile but untreated population.

Conclusions

Use of any assisted conception was associated with poorer perinatal outcomes for singletons than their spontaneously conceived counterparts. Diagnosed untreated infertility was associated with poor perinatal outcomes, but treatment of infertility at a different time was not. Outcomes from ICSI with fresh-embryo transfer and from IVF with frozen-embryo transfer were better than those from IVF with fresh-embryo transfer. ICSI with frozen-embryo transfer, despite lower per-cycle take-home baby rates and per-transfer singleton live birth rates [44], [45] does not appear to have worse outcomes than spontaneous conception, suggesting the procedure may select for healthier embryos or reflect differences in the characteristics of patients who have access to cryopreservation. However this type of assisted conception was associated with a greater risk of macrosomia. OI alone modestly increased the risk of low birth weight and preterm birth, a concern given its longstanding tenure as a first-line therapy, and its frequency of use. The comprehensive series of disadvantages among births following infertility treatment warrants routine monitoring and aetiological research.

Supporting Information

Table S1.

Categories of assisted conception treatments for the time periods 1986–1992, 1993–1999 and 2000–2002.

doi:10.1371/journal.pone.0080398.s001

(DOCX)

Acknowledgments

We thank Flinders Reproductive Medicine and Repromed in Adelaide for providing clinical data.

Author Contributions

Conceived and designed the experiments: JLM VMM MJD. Analyzed the data: KJW. Contributed reagents/materials/analysis tools: KJW LCG AR MJW. Wrote the paper: JLM VMM KJW AR MJW LCG MJD.

References

  1. 1. Myers E, McCrory D, Mills A, Price T, Swamy G, et al.. (2008) Evidence Report/Technology Assessment No. 167. Effectiveness of Assisted Reproductive Technology. Rockville, MD, USA: Agency for Healthcare Research and Quality.
  2. 2. Reddy UM, Wapner RJ, Rebar RW, Tasca RJ (2007) Infertility, assisted reproductive technology, and adverse pregnancy outcomes: executive summary of a National Institute of Child Health and Human Development workshop. Obstet Gynecol 109: 967–977.
  3. 3. Bower C, Hansen M (2005) Assisted reproductive technologies and birth outcomes: overview of recent systematic reviews. Reprod Fertil Dev 17: 329–333.
  4. 4. Jackson RA, Gibson KA, Wu YW, Croughan MS (2004) Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol 103: 551–563.
  5. 5. Helmerhorst FM, Perquin DA, Donker D, Keirse MJ (2004) Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies. BMJ 328: 261.
  6. 6. Barnhart KT (2013) Assisted reproductive technologies and perinatal morbidity: interrogating the association. Fertil steril 99: 299–302.
  7. 7. Jaques AM, Amor DJ, Baker HW, Healy DL, Ukoumunne OC, et al. (2010) Adverse obstetric and perinatal outcomes in subfertile women conceiving without assisted reproductive technologies. Fertil Steril 94: 2674–2679.
  8. 8. Zhu JL, Obel C, Hammer Bech B, Olsen J, Basso O (2007) Infertility, infertility treatment, and fetal growth restriction. Obstet Gynecol 110: 1326–1334.
  9. 9. Basso O, Baird DD (2003) Infertility and preterm delivery, birthweight, and Caesarean section: a study within the Danish National Birth Cohort. Hum Reprod 18: 2478–2484.
  10. 10. Axmon A, Hagmar L (2005) Time to pregnancy and pregnancy outcome. Fertil Steril 84: 966–974.
  11. 11. Wisborg K, Ingerslev HJ, Henriksen TB (2010) In vitro fertilization and preterm delivery, low birth weight, and admission to the neonatal intensive care unit: a prospective follow-up study. Fertil Steril 94: 2102–2106.
  12. 12. De Geyter C, De Geyter M, Steimann S, Zhang H, Holzgreve W (2006) Comparative birth weights of singletons born after assisted reproduction and natural conception in previously infertile women. Hum Reprod 21: 705–712.
  13. 13. Davies MJ, Moore VM, Willson KJ, Van Essen P, Priest K, et al. (2012) Reproductive technologies and the risk of birth defects. N Engl J Med 366: 1803–1813.
  14. 14. Roberts CL, Lancaster PA (1999) Australian national birthweight percentiles by gestational age. Med J Aust 170: 114–118.
  15. 15. Roberts CL, Lancaster PA (1999) National birthweight percentiles by gestational age for twins born in Australia. J Paediatr Child Health 35: 278–282.
  16. 16. Schieve LA, Meikle SF, Ferre C, Peterson HB, Jeng G, et al. (2002) Low and very low birth weight in infants conceived with use of assisted reproductive technology. N Engl J Med 346: 731–737.
  17. 17. Wisborg K, Ingerslev HJ, Henriksen TB (2010) IVF and stillbirth: a prospective follow-up study. Human Reproduction 25: 1312–1316.
  18. 18. Fujii M, Matsuoka R, Bergel E, van der Poel S, Okai T (2010) Perinatal risk in singleton pregnancies after in vitro fertilization. Fertil Steril 94: 2113–2117.
  19. 19. Wang JX, Clark AM, Kirby CA, Philipson G, Petrucco O, et al. (1994) The obstetric outcome of singleton pregnancies following in-vitro fertilization/gamete intra-fallopian transfer. Hum Reprod 9: 141–146.
  20. 20. Kallen B, Finnstrom O, Nygren KG, Olausson PO (2005) In vitro fertilization (IVF) in Sweden: infant outcome after different IVF fertilization methods. Fertil Steril 84: 611–617.
  21. 21. Shih W, Rushford DD, Bourne H, Garrett C, McBain JC, et al. (2008) Factors affecting low birthweight after assisted reproduction technology: difference between transfer of fresh and cryopreserved embryos suggests an adverse effect of oocyte collection. Hum Reprod 23: 1644–1653.
  22. 22. Klemetti R, Sevon T, Gissler M, Hemminki E (2010) Health of children born after ovulation induction. Fertil Steril 93: 1157–1168.
  23. 23. Ombelet W, Martens G, De Sutter P, Gerris J, Bosmans E, et al. (2006) Perinatal outcome of 12,021 singleton and 3108 twin births after non-IVF-assisted reproduction: a cohort study. Hum Reprod 21: 1025–1032.
  24. 24. Addor V, Santos-Eggimann B, Fawer CL, Paccaud F, Calame A (1998) Impact of infertility treatments on the health of newborns. Fertil Steril 69: 210–215.
  25. 25. Pelkonen S, Koivunen R, Gissler M, Nuojua-Huttunen S, Suikkari AM, et al. (2010) Perinatal outcome of children born after frozen and fresh embryo transfer: the Finnish cohort study 1995–2006. Hum Reprod 25: 914–923.
  26. 26. Pinborg A, Loft A, Aaris Henningsen AK, Rasmussen S, Andersen AN (2010) Infant outcome of 957 singletons born after frozen embryo replacement: the Danish National Cohort Study 1995–2006. Fertil Steril 94: 1320–1327.
  27. 27. Wang YA, Sullivan EA, Black D, Dean J, Bryant J, et al. (2005) Preterm birth and low birth weight after assisted reproductive technology-related pregnancy in Australia between 1996 and 2000. Fertil Steril 83: 1650–1658.
  28. 28. Wada I, Macnamee MC, Wick K, Bradfield JM, Brinsden PR (1994) Birth characteristics and perinatal outcome of babies conceived from cryopreserved embryos. Hum Reprod 9: 543–546.
  29. 29. Wennerholm UB, Hagberg H, Brorsson B, Bergh C (2009) Induction of labor versus expectant management for post-date pregnancy: is there sufficient evidence for a change in clinical practice? Acta Obstet Gynecol Scand 88: 6–17.
  30. 30. Maheshwari A, Pandi S, Shetty A, Hamilton M, Bhattacharya S (2012) Obstetric and perinatal outcomes in singleton pregnancies resulting from the transfer of frozen thawed versus fresh embryos generated through in vitro fertilization treatment: a systematic review and meta-analysis. Fertil steril 98: 368–377.
  31. 31. Sazonova A, Källen K, Thurin-Kjellberg A, Wennerholm U-B, Bergh C (2012) Obstetric outcome in singletons after in vitro fertilization with cryopreserved/thawed embryos. Human Reproduction 27: 1343–1350.
  32. 32. Wennerholm U-B, Henningsen A-KA, Romundstad LB, Bergh C, Pinborg A, et al. (2013) Perinatal outcomes of children born after frozen-thawed embryo transfer: a Nordic cohort study from the CoNARTaS group. Human Reproduction 28: 2545–2553.
  33. 33. Chason RJ, Csokmay J, Segars JH, DeCherney AH, Armant DR (2011) Environmental and epigenetic effects upon preimplantation embryo metabolism and development. Trends Endocrinol Metab 22: 412–420.
  34. 34. Nohr EA, Bech BH, Davies MJ, Frydenberg M, Henriksen TB, et al. (2005) Prepregnancy obesity and fetal death: a study within the Danish National Birth Cohort. Obstet Gynecol 106: 250–259.
  35. 35. Thomson F, Shanbhag S, Templeton A, Bhattacharya S (2005) Obstetric outcome in women with subfertility. BJOG 112: 632–637.
  36. 36. Pinborg A, Wennerholm UB, Romundstad LB, Loft A, Aittomaki K, et al. (2013) Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta-analysis. Human Reproduction Update 19: 87–104.
  37. 37. Marino JL, Moore VM, Rumbold AR, Davies MJ (2011) Fertility treatments and the young women who use them: an Australian cohort study. Hum Reprod 26: 473–479.
  38. 38. Kallen B, Finnstrom O, Lindam A, Nilsson E, Nygren KG, et al. (2010) Selected neonatal outcomes in dizygotic twins after IVF versus non-IVF pregnancies. BJOG 117: 676–682.
  39. 39. Boulet SL, Schieve LA, Nannini A, Ferre C, Devine O, et al. (2008) Perinatal outcomes of twin births conceived using assisted reproduction technology: a population-based study. Hum Reprod 23: 1941–1948.
  40. 40. Shebl O, Ebner T, Sommergruber M, Sir A, Tews G (2008) Risk in twin pregnancies after the use of assisted reproductive techniques. J Reprod Med 53: 798–802.
  41. 41. Ananth C, Platt R, Savitz D (2005) Regression models for clustered binary responses: implications of ignoring the intracluster correlation in an analysis of perinatal mortality in twin gestations. Annals of Epidemiology 15: 293–301.
  42. 42. Källén B, Finnström O, Lindam A, Nilsson E, Nygren K-G, et al. (2010) Trends in delivery and neonatal outcome after in vitro fertilization in Sweden: data for 25 years. Human Reproduction 25: 1026–1034.
  43. 43. Macaldowie A, Wang Y, Chambers G, Sullivan E (2012) Assisted reproductive technology in Australia and New Zealand 2010. Canberra: AIHW.
  44. 44. Nelson SM, Lawlor DA (2011) Predicting live birth, preterm delivery, and low birth weight in infants born from in vitro fertilisation: a prospective study of 144,018 treatment cycles. PLoS Med 8: e1000386.
  45. 45. South Australian Council on Reproductive Technology (2007) Annual report to the Minister of Health. Adelaide.